rs771227297
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001365536.1(SCN9A):c.560C>T(p.Pro187Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 27 | ENSP00000495983.1 | ||||
SCN9A | ENST00000454569.6 | c.560C>T | p.Pro187Leu | missense_variant | Exon 5 of 15 | 1 | ENSP00000413212.2 | |||
SCN9A | ENST00000452182.2 | c.560C>T | p.Pro187Leu | missense_variant | Exon 6 of 11 | 1 | ENSP00000393141.2 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151802Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249028Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135112
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461360Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 726962
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151802Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74126
ClinVar
Submissions by phenotype
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 187 of the SCN9A protein (p.Pro187Leu). This variant is present in population databases (rs771227297, gnomAD 0.003%). This missense change has been observed in individual(s) with erythromelalgia (PMID: 29911575). ClinVar contains an entry for this variant (Variation ID: 574441). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SCN9A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Generalized epilepsy with febrile seizures plus, type 7 Uncertain:1
The de novo c.560C>T (p.Pro187Leu) variant identified in the SCN9A gene substitutes a well conserved Proline for Leucine at amino acid 187/1978 (coding exon 5/27). This variant is found with low frequency in gnomAD(v3.0) (3 heterozygotes, 0 homozygotes; allele frequency 2.1e-5) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Deleterious (Provean; score: -9.6), Damaging (SIFT; score:0.000) and Pathogenic (REVEL; score:0.7919) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID:57441), and to our current knowledge has not been reported in any individuals with SCN9A associated seizure disorder. The p.Pro187Leu variant has however been reported in a 71y female with Erythermalgia, although it is unclear if that individual had a history of seizures [PMID:29911575]. SCN9A is a transmembrane protein, and the p.Pro187 residue is predicted to be the last amino acid within the cytoplasmic loop at the S3 repeat of transmembrane domain 1 (UniProtKB: Q15858). While it is identified de novo in this individual, its presence in control and non-neuro population databases (gnomADv2.1.1, rs771227297) and observation in an individual in association with Erythromelalgia leaves some uncertainty regarding its role in SCN9A associated seizure disorder. The c.560C>T (p.Pro187Leu) variant identified in the SCN9A gene is therefore classified here as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at